Cord Blood America, Inc. (CBAI.OB), reports that researchers at the University of Texas Medical Branch at Galveston who announced, in Science Daily, that they have engineered adult stem cells from human umbilical cord blood to produce insulin.
This fundamental discovery could help cure type I diabetes by allowing people to grow their own insulin-producing cells for a damaged or defective pancreas, the Texas researchers said.
“Diabetes is a far more common affliction than cancer and leukemia, traditionally treated with stem cells,” said Matthew Schissler, Cord Blood America CEO. “The progress with stem cells to treat Type I diabetes may logically grow our potential customer base exponentially.”
Let us hear your thoughts below:
